What It Is
HGH 191AA refers to recombinant human growth hormone, more precisely known as somatropin — a laboratory-made version of the 191-amino-acid hormone naturally produced by the pituitary gland.[1] The "191AA" label distinguishes it from an older recombinant form, somatrem, which carried an extra methionine (192 amino acids total). Modern prescription growth hormone products such as Genotropin, Humatrope, and Norditropin are manufactured to match this native 191-amino-acid sequence.
"191AA" only describes which molecule a product claims to be, not whether it is pure, correctly dosed, or made under sterile, regulated conditions — a distinction that matters most for growth hormone sold outside licensed pharmacy channels as a "research chemical."
How It Works
Somatropin works by binding to growth hormone receptors on target cells, activating an intracellular signaling cascade known as the JAK2/STAT pathway.[2] This affects protein, carbohydrate, lipid, and mineral metabolism, and prompts the liver to produce IGF-1, a growth factor that carries out much of the downstream biological work traditionally credited to growth hormone itself.
In children with open growth plates, this axis drives skeletal growth; in adults it instead shapes body composition, tissue repair, and metabolic regulation — one reason growth hormone's approved uses differ so much between pediatric and adult patients.
What the Research Shows
The clinical evidence for growth hormone therapy is strongest in patients with a confirmed deficiency. In adults with diagnosed growth hormone deficiency, endocrine society guidance describes measurable benefits in body composition, exercise capacity, and quality of life, while noting that insulin resistance can rise and that no study has established a mortality benefit.[3]
That evidence does not extend to healthy people using growth hormone for anti-aging or performance purposes. A widely cited meta-analysis in healthy older adults found small favorable body-composition shifts alongside a notably higher rate of adverse events such as fluid retention, joint pain, and carpal tunnel syndrome, and concluded growth hormone could not be recommended as an anti-aging therapy.[4]
Safety & Side Effects
Somatropin's adult side-effect profile is well documented in FDA-approved labeling. Commonly reported issues include:
- Fluid retention, swelling, and joint or muscle pain
- Nerve-compression symptoms such as tingling and carpal tunnel syndrome
- Reduced glucose tolerance and effects on insulin sensitivity
- Rare but serious intracranial hypertension, usually reversible after dose adjustment
Labeling also identifies hard contraindications, including active malignancy and acute critical illness, where pharmacologic dosing has been linked to increased mortality. These risks are characterized for a regulated pharmaceutical used under medical supervision; growth hormone obtained through "research use only" channels adds unquantified risk around sterility, actual content, and dosing accuracy.
Regulatory Status
In the United States, somatropin is an FDA-approved prescription drug, but strictly for defined indications such as certain pediatric growth disorders and confirmed adult growth hormone deficiency. It is not approved for anti-aging use, general fitness, weight loss, or bodybuilding.[5]
Federal law adds a specific criminal penalty: 21 U.S.C. § 333(e) makes it an offense to distribute human growth hormone for any purpose other than physician-directed treatment of a recognized medical condition. Growth hormone marketed online as a "research peptide" sits entirely outside that framework — it is unapproved product, not a cheaper version of the same medicine.
Doping & Sports Testing
Because growth hormone can influence lean mass, recovery, and metabolism, it — along with its analogues, fragments, and secretagogues — appears on the World Anti-Doping Agency's Prohibited List.[6] Athletes subject to drug testing should treat HGH 191AA, and related compounds like sermorelin, CJC-1295, ipamorelin, and MK-677, as banned substances regardless of how casually they are marketed for general wellness.